loadpatents
name:-0.03308892250061
name:-0.03987717628479
name:-0.0017540454864502
Lynch; Kevin R. Patent Filings

Lynch; Kevin R.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Lynch; Kevin R..The latest application filed is for "inhibitors of spinster homolog 2 (spns2) for use in therapy".

Company Profile
1.34.33
  • Lynch; Kevin R. - Charlottesville VA
  • Lynch, Kevin R - Charlottesville VA
  • Lynch; Kevin R. - Somerville MA
  • Lynch; Kevin R. - Sommerville MA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Inhibitors Of Spinster Homolog 2 (spns2) For Use In Therapy
App 20220089581 - Lynch; Kevin R. ;   et al.
2022-03-24
Sphingosine kinase inhibitor amidoxime prodrugs
Grant 11,180,489 - Thorpe , et al. November 23, 2
2021-11-23
Sphingosine Kinase Inhibitor Amidoxime Prodrugs
App 20200308159 - Thorpe; Steven Brandon ;   et al.
2020-10-01
Sphingosine kinase inhibitors
Grant 10,100,022 - Lynch , et al. October 16, 2
2018-10-16
Imidamide sphingosine kinase inhibitors
Grant 9,908,849 - Lynch , et al. March 6, 2
2018-03-06
Sphingosine Kinase Inhibitors
App 20170298032 - Lynch; Kevin R. ;   et al.
2017-10-19
Long chain base sphingosine kinase inhibitors
Grant 9,688,668 - Santos , et al. June 27, 2
2017-06-27
Compositions and methods for tissue engineering and cell based therapies
Grant 9,682,078 - Botchwey, III , et al. June 20, 2
2017-06-20
Imidamide Sphingosine Kinase Inhibitors
App 20170166525 - Lynch; Kevin R. ;   et al.
2017-06-15
Imidamide sphingosine kinase inhibitors
Grant 9,421,177 - Lynch , et al. August 23, 2
2016-08-23
Long Chain Base Sphingosine Kinase Inhibitors
App 20150210675 - Webster; Santos L. ;   et al.
2015-07-30
Compositions And Methods For Tissue Engineering And Cell Based Therapies
App 20140094444 - Botchwey, III; Edward A. ;   et al.
2014-04-03
Compositions and methods for inhibiting sphingosine kinase
Grant 8,686,046 - Lynch , et al. April 1, 2
2014-04-01
Phosphonate derivatives as autotaxin inhibitors
Grant 8,378,100 - Lynch , et al. February 19, 2
2013-02-19
Cycloalkane-containing sphingosine 1-phosphate agonists
Grant 8,329,676 - Lynch , et al. December 11, 2
2012-12-11
Vinyl phosphonate lysophosphatidic acid receptor antagonists
Grant 8,283,339 - Carter , et al. October 9, 2
2012-10-09
Imidamide Sphingosine Kinase Inhibitors
App 20120214858 - Lynch; Kevin R. ;   et al.
2012-08-23
Bicyclic sphingosine 1-phosphate analogs
Grant 8,173,710 - Lynch , et al. May 8, 2
2012-05-08
Cycloalkane-containing Sphingosine 1-phosphate Agonists
App 20110245204 - Lynch; Kevin R. ;   et al.
2011-10-06
Method for treatment of neuropathic pain
Grant 8,008,286 - Lynch , et al. August 30, 2
2011-08-30
Bicyclic Sphingosine 1-phosphate Analogs
App 20110195936 - Lynch; Kevin R. ;   et al.
2011-08-11
Hydrindane analogs having sphingosine 1-phosphate receptor agonist activity
Grant 7,964,649 - Lynch , et al. June 21, 2
2011-06-21
Benzyl cycloalkyl sphingosine 1-phosphate receptor modulators
Grant 7,960,588 - Lynch , et al. June 14, 2
2011-06-14
Compositions And Methods For Inhibiting Sphingosine Kinase
App 20110106241 - Lynch; Kevin R. ;   et al.
2011-05-05
Benzocycloheptyl analogs having sphingosine 1-phosphate receptor activity
Grant 7,915,315 - Lynch , et al. March 29, 2
2011-03-29
Aryl amide sphingosine 1-phosphate analogs
Grant 7,888,527 - Lynch , et al. February 15, 2
2011-02-15
Lysophosphatidic acid receptor selective antagonists
Grant 7,820,703 - Lynch , et al. October 26, 2
2010-10-26
Benzyl-cycloalkyl Sphingosine 1-phosphate Receptor Modulators
App 20100249074 - Lynch; Kevin R. ;   et al.
2010-09-30
Bicyclic Sphingosine 1-phosphate Analogs
App 20100240617 - Lynch; Kevin R. ;   et al.
2010-09-23
Tetralin analogs having sphingosine 1-phosphate agonist activity
Grant 7,786,173 - Lynch , et al. August 31, 2
2010-08-31
Cycloalkane-containing sphingosine 1-phosphate agonists
Grant 7,754,703 - Lynch , et al. July 13, 2
2010-07-13
Phosphonate Derivatives As Autotaxin Inhibitors
App 20100016258 - Lynch; Kevin R. ;   et al.
2010-01-21
Orally available sphingosine 1-phosphate receptor agonists and antagonists
Grant 7,638,637 - Lynch , et al. December 29, 2
2009-12-29
Hydrindane Analogs Having Sphingosine 1-phosphate Receptor Agonist Activity
App 20090253760 - Lynch; Kevin R. ;   et al.
2009-10-08
Tetralin Analogs Having Sphingosine 1-phosphate Agonist Activity
App 20090253759 - Lynch; Kevin R. ;   et al.
2009-10-08
Benzocycloheptyl Analogs Having Sphingosine 1-phosphate Receptor Activity
App 20090253761 - Lynch; Kevin R. ;   et al.
2009-10-08
Vinyl Phosphonate Lysophosphatidic Acid Receptor Antagonists
App 20090197835 - Carter; Karen M. ;   et al.
2009-08-06
Compounds active in sphingosine 1-phosphate signaling
Grant 7,560,477 - Lynch , et al. July 14, 2
2009-07-14
Aryl Amide Sphingosine 1-
App 20090137531 - Lynch; Kevin R. ;   et al.
2009-05-28
Phenyl-cycloalkyl And Phenyl-heterocyclic Derivatives As S1p Receptor Agonists
App 20090105315 - Lynch; Kevin R. ;   et al.
2009-04-23
Method For Treatment Of Neuropathic Pain
App 20090062238 - Lynch; Kevin R. ;   et al.
2009-03-05
Bicyclic Sphingosine 1-phosphate Analogs
App 20090042955 - LYNCH; Kevin R. ;   et al.
2009-02-12
Novel Lysophosphatidic Acid Receptor Selective Antagonists
App 20080318901 - Lynch; Kevin R. ;   et al.
2008-12-25
Cycloalkane-Containing Sphingosine 1-Phospate Agonists
App 20080249070 - Lynch; Kevin R. ;   et al.
2008-10-09
Compounds Active in Sphingosine 1-Phosphate Signaling
App 20070219163 - Lynch; Kevin R. ;   et al.
2007-09-20
Compounds active in spinigosine 1-phosphate signaling
Grant 7,241,790 - Lynch , et al. July 10, 2
2007-07-10
Orally available sphingosine 1-phosphate receptor agonists and antagonists
App 20070088002 - Lynch; Kevin R. ;   et al.
2007-04-19
Lysophosphatidic acid receptor agonists and antagonists
Grant 7,169,818 - Lynch , et al. January 30, 2
2007-01-30
Neuromedin U receptor NMUR2 and nucleotides encoding it
Grant 7,163,799 - Liu , et al. January 16, 2
2007-01-16
Agonists and antagonists of sphingosine-1-phosphate receptors
Grant 7,064,217 - Macdonald , et al. June 20, 2
2006-06-20
Compounds active in spinigosine 1-phosphate signaling
App 20050222422 - Lynch, Kevin R. ;   et al.
2005-10-06
Novel lysophosphatidic acid receptor agonists and antagonists
App 20050107447 - Lynch, Kevin R. ;   et al.
2005-05-19
Novel lysophosphatidic acid receptor agonists and antagonists
App 20040122236 - Lynch, Kevin R. ;   et al.
2004-06-24
Agonists and antagonists of sphingosine-1-phosphate receptors
App 20040110728 - Macdonald, Timothy L. ;   et al.
2004-06-10
Neuromedin u receptor nmur2 and nucleotides encoding it
App 20030211968 - Liu, Qingyun ;   et al.
2003-11-13
Galanin receptor GALR3 and nucleotides encoding same
App 20030023074 - Howard, Andrew D. ;   et al.
2003-01-30
System and method for performing bulge testing of films, coatings and/or layers
Grant 6,349,588 - Brown , et al. February 26, 2
2002-02-26
System and method for performing bulge testing of films, coatings and/or layers
Grant 6,321,594 - Brown , et al. November 27, 2
2001-11-27
System and method for performing bulge testing of films, coatings and/or layers
Grant 6,050,138 - Lynch , et al. April 18, 2
2000-04-18
Nucleic acid encoding the growth hormone releasing hormone receptor
Grant 5,612,470 - Thorner , et al. * March 18, 1
1997-03-18
Nucleic acid encoding the growth hormone releasing hormone receptor
Grant 5,591,641 - Thorner , et al. * January 7, 1
1997-01-07
Company Registrations
CAGE Code45W45LYNCH, KEVIN R KEVIN R. LYNCH
DUNS605449656LYNCH, KEVIN R

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed